BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15523411)

  • 1. Re: "Thorough intraoperative analysis of breast sentinel lymph node biopsies: Histologic and immunohistochemical findings".
    Griswold RD
    Surgery; 2004 Nov; 136(5):1101-2. PubMed ID: 15523411
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: "The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators".
    Sasada T; Takabayashi A
    Surgery; 2004 Nov; 136(5):1101. PubMed ID: 15523412
    [No Abstract]   [Full Text] [Related]  

  • 3. Overexpression of interleukin-10 in sentinel lymph node with breast cancer.
    Woo SU; Bae JW; Yang JH; Kim JH; Nam SJ; Shin YK
    Ann Surg Oncol; 2007 Nov; 14(11):3268-73. PubMed ID: 17762971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of tumour infiltrating lymphocytes in human breast cancer.
    Chin Y; Janssens J; Bleus J; Vandepitte J; Vandenbrande J; Raus J
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():27-31. PubMed ID: 8298448
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sentinel lymph node biopsy under local anaesthesia: how to avoid the disadvantages of intraoperative examination?].
    Bouquier J; Clément D; Morel O; Lousquy R; Malartic C; Barranger E
    Gynecol Obstet Fertil; 2008 Jan; 36(1):79-84. PubMed ID: 18191603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy in breast cancer.
    Fortunato L; Mascaro A; Amini M; Farina M; Vitelli CE
    Surg Oncol Clin N Am; 2008 Jul; 17(3):673-99, x. PubMed ID: 18486889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of tumor-infiltrating antigen presenting cells by high intensity focused ultrasound ablation of human breast cancer.
    Xu ZL; Zhu XQ; Lu P; Zhou Q; Zhang J; Wu F
    Ultrasound Med Biol; 2009 Jan; 35(1):50-7. PubMed ID: 18950932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How to avoid the uncertainties of intraoperative examination of the sentinel lymph node in breast cancer?].
    Aubard Y; Mollard J; Fermeaux V
    Gynecol Obstet Fertil; 2004 Nov; 32(11):981-4. PubMed ID: 15567689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
    Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
    Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer pseudometastasis in a sentinel lymph node with cytokeratin-positive debris.
    Rao RS; Taylor J; Palmer J; Jennings WC
    Breast J; 2005; 11(2):134-7. PubMed ID: 15730460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative imprint cytology in assessment of sentinel lymph nodes and lumpectomy surgical margins.
    Hakam A; Khin NN
    Clin Lab Med; 2005 Dec; 25(4):795-807, viii. PubMed ID: 16308093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in intramammary sentinel lymph node removal using a novel prototype hand held probe during breast conservative surgery.
    Mathelin C; Tomasetto C; Rio MC; Chenard MP; Brettes JP; Guyonnet JL
    Breast Cancer Res Treat; 2005 Feb; 89(3):305-8. PubMed ID: 15754130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?
    Degnim AC; Oh K; Cimmino VM; Diehl KM; Chang AE; Newman LA; Sabel MS
    Ann Surg Oncol; 2005 Sep; 12(9):712-7. PubMed ID: 16079955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
    Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
    Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
    de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW
    Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches in breast cancer management: sentinel node biopsy and intraoperative radiotherapy.
    Keshtgar MR; Chicken DW; Tobias JS
    Int J Fertil Womens Med; 2005; 50(5 Pt 1):218-26. PubMed ID: 16468472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of sentinel node in breast cancer].
    Vergara-Fernández O; Cortés-González R; Medina-Franco H
    Rev Invest Clin; 2004; 56(3):309-13. PubMed ID: 15612512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of the sentinel lymph nodes status in breast carcinoma using microscopic, immunohistochemical and cytomorphometric methods in order to establish new stadializations and therapeutic schemes.
    Stolnicu S; Coros MF; Podeanu DM; Carata E; Mezei T; Muscă S; Podoleanu C; Rădulescu D
    Rom J Morphol Embryol; 2009; 50(1):51-60. PubMed ID: 19221645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of technologies for sentinel lymph node biopsy in case of breast cancer].
    Mathelin C; Piqueras I; Guyonnet JL
    Gynecol Obstet Fertil; 2006 Jun; 34(6):521-5. PubMed ID: 16750414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Less is more: transmammary axillary lymph node evaluation: an initial clinical experience.
    Cocilovo C; Boolbol SK; Valdes E; Feldman S
    Am J Surg; 2006 Oct; 192(4):478-80. PubMed ID: 16978953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.